International Conference on Healthy Longevity
The First International Conference on Healthy Longevity featured David Sinclair, one of the world’s leading researchers in aging science.
Read MoreNo products in the cart.
The First International Conference on Healthy Longevity featured David Sinclair, one of the world’s leading researchers in aging science.
Read More
Zona della Risoluzione expands Barry Sears’ pioneering work on silent inflammation and resolution science. Through targeted nutrition strategies, protective factors, and a deep understanding of chronic disease mechanisms, the book outlines a practical roadmap to improve health, prevent degenerative conditions, and enhance longevity.
Read More
Camillo Ricordi’s introduction to the Italian edition of David Sinclair’s Lifespan, presenting ageing as a potentially reversible disease and exploring the role of epigenetics, novel anti-ageing molecules and the ethical imperative of extending healthy lifespan.
Read More
Real-life case series of four severe ICU COVID-19 patients treated with eculizumab: all achieved clinical recovery, with marked CRP reduction and a mean disease duration of about 13 days, supporting the potential role of anti-complement C5 therapy in severe cases.
Read More
Preliminary (March 2020) review examining in vitro studies, clinical trials, expert reports and COVID-19 prevalence in malaria and non-malaria countries to explore the hypothesis that chloroquine and hydroxychloroquine might be effective in treating COVID-19.
Read More
A scientific and educational volume exploring the COVID-19 pandemic across all dimensions: clinical aspects, diagnosis, treatments, social impact, healthcare, risk factors and institutional responses, enriched with expert contributions.
Read More
Editorial highlighting vitamin D status as an important modulator of innate immunity and natural defense against acute viral respiratory infections, with potential clinical and preventive implications.
Read More
New edition of the Manuale di Medicina Ambulatoriale, updated for the COVID-19 pandemic and expanded with sections on cancer screening, chronic conditions and regulatory and clinical tools to support physicians working in outpatient settings.
Read More
Case report on the use of Point-of-Care lung ultrasound in a COVID-19 patient, highlighting its advantages during the pandemic: rapid assessment, reduced exposure, repeatability and suitability for low-resource settings.
Read More
Case series describing four severe ICU COVID-19 patients treated with eculizumab at ASL Napoli 2 Nord: all patients recovered, with marked CRP reduction and a mean disease duration of about 13 days, suggesting a potential role for anti-complement C5 therapy as a therapeutic option.
Read More